메뉴 건너뛰기




Volumn 1, Issue 7, 2016, Pages 831-841

Adult stem cell therapy and heart failure, 2000 to 2016: A systematic review

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT STEM CELL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIAC DERIVED STEM CELL; CELL REGENERATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; ISCHEMIC CARDIOMYOPATHY; MESENCHYMAL STEM CELL; META ANALYSIS (TOPIC); NONISCHEMIC CARDIOMYOPATHY; PARACRINE SIGNALING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); BIOLOGICAL THERAPY; HEART; HEMATOPOIETIC STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 85027763639     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.2225     Document Type: Review
Times cited : (234)

References (76)
  • 1
    • 84922381210 scopus 로고    scopus 로고
    • Heart disease and stroke statistics–2015 update: A report from the American Heart Association
    • Mozaffarian D, Benjamin EJ, Go AS, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131 (4):e29-e322.
    • (2015) Circulation , vol.131 , Issue.4 , pp. e29-e322
    • Mozaffarian, D.1    Benjamin, E.J.2    Go, A.S.3
  • 2
    • 84864453582 scopus 로고    scopus 로고
    • Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: A systematic review and meta-analysis
    • Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126(5): 551-568.
    • (2012) Circulation , vol.126 , Issue.5 , pp. 551-568
    • Jeevanantham, V.1    Butler, M.2    Saad, A.3    Abdel-Latif, A.4    Zuba-Surma, E.K.5    Dawn, B.6
  • 3
    • 84930787836 scopus 로고    scopus 로고
    • Meta-analysis of cell therapy trials for patients with heart failure
    • Fisher SA, Doree C, Mathur A, Martin-Rendon E. Meta-analysis of cell therapy trials for patients with heart failure. Circ Res. 2015;116(8):1361-1377.
    • (2015) Circ Res , vol.116 , Issue.8 , pp. 1361-1377
    • Fisher, S.A.1    Doree, C.2    Mathur, A.3    Martin-Rendon, E.4
  • 4
    • 84929003354 scopus 로고    scopus 로고
    • Meta-Analysis of Cell-based Cardiac Studies (ACCRUE) in patients with acute myocardial infarction based on individual patient data
    • Gyöngyösi M, Wojakowski W, Lemarchand P, et al; ACCRUE Investigators. Meta-Analysis of Cell-based Cardiac Studies (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015;116(8): 1346-1360.
    • (2015) Circ Res , vol.116 , Issue.8 , pp. 1346-1360
    • Gyöngyösi, M.1    Wojakowski, W.2    Lemarchand, P.3
  • 5
    • 84898992845 scopus 로고    scopus 로고
    • Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: A collaborative meta-analysis
    • Delewi R, Hirsch A, Tijssen JG, et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J. 2014;35(15):989-998.
    • (2014) Eur Heart J , vol.35 , Issue.15 , pp. 989-998
    • Delewi, R.1    Hirsch, A.2    Tijssen, J.G.3
  • 6
    • 2442675144 scopus 로고    scopus 로고
    • Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation
    • Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10(5):494-501.
    • (2004) Nat Med , vol.10 , Issue.5 , pp. 494-501
    • Nygren, J.M.1    Jovinge, S.2    Breitbach, M.3
  • 7
    • 0035810240 scopus 로고    scopus 로고
    • Bone marrow cells regenerate infarcted myocardium
    • Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701-705.
    • (2001) Nature , vol.410 , Issue.6829 , pp. 701-705
    • Orlic, D.1    Kajstura, J.2    Chimenti, S.3
  • 9
    • 84857604290 scopus 로고    scopus 로고
    • Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use
    • Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012;110(4):624-637.
    • (2012) Circ Res , vol.110 , Issue.4 , pp. 624-637
    • Fadini, G.P.1    Losordo, D.2    Dimmeler, S.3
  • 10
    • 7244242362 scopus 로고    scopus 로고
    • Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood
    • Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104(9):2752-2760.
    • (2004) Blood , vol.104 , Issue.9 , pp. 2752-2760
    • Ingram, D.A.1    Mead, L.E.2    Tanaka, H.3
  • 11
    • 20244389882 scopus 로고    scopus 로고
    • Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
    • Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11(4):367-368.
    • (2005) Nat Med. , vol.11 , Issue.4 , pp. 367-368
    • Gnecchi, M.1    He, H.2    Liang, O.D.3
  • 12
    • 84926302688 scopus 로고    scopus 로고
    • Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplant
    • Stempien-Otero A, Helterline D, Plummer T, et al. Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplant. J Am Coll Cardiol. 2015;65(14):1424-1434.
    • (2015) J Am Coll Cardiol , vol.65 , Issue.14 , pp. 1424-1434
    • Stempien-Otero, A.1    Helterline, D.2    Plummer, T.3
  • 13
    • 84899980641 scopus 로고    scopus 로고
    • Exosomes as critical agents of cardiac regeneration triggered by cell therapy
    • Ibrahim AG, Cheng K, Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2014;2(5):606-619.
    • (2014) Stem Cell Reports , vol.2 , Issue.5 , pp. 606-619
    • Ibrahim, A.G.1    Cheng, K.2    Marbán, E.3
  • 14
    • 84955301496 scopus 로고    scopus 로고
    • More than tiny sacks: Stem cell exosomes as cell-free modality for cardiac repair
    • Kishore R, Khan M. More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ Res. 2016;118(2):330-343.
    • (2016) Circ Res , vol.118 , Issue.2 , pp. 330-343
    • Kishore, R.1    Khan, M.2
  • 15
    • 84883445522 scopus 로고    scopus 로고
    • Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms
    • Duran JM, Makarewich CA, Sharp TE, et al. Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res. 2013; 113(5):539-552.
    • (2013) Circ Res , vol.113 , Issue.5 , pp. 539-552
    • Duran, J.M.1    Makarewich, C.A.2    Sharp, T.E.3
  • 16
    • 58149347238 scopus 로고    scopus 로고
    • Paracrine mechanisms in adult stem cell signaling and therapy
    • Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11):1204-1219.
    • (2008) Circ Res , vol.103 , Issue.11 , pp. 1204-1219
    • Gnecchi, M.1    Zhang, Z.2    Ni, A.3    Dzau, V.J.4
  • 17
    • 0034988303 scopus 로고    scopus 로고
    • Bone marrow stromal stem cells: Nature, biology, and potential applications
    • Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19(3): 180-192.
    • (2001) Stem Cells , vol.19 , Issue.3 , pp. 180-192
    • Bianco, P.1    Riminucci, M.2    Gronthos, S.3    Robey, P.G.4
  • 18
    • 24644474680 scopus 로고    scopus 로고
    • Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety
    • Bartunek J, Vanderheyden M, Vandekerckhove B, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation. 2005;112(9) (suppl):I178-I183.
    • (2005) Circulation , vol.112 , Issue.9 , pp. I178-I183
    • Bartunek, J.1    Vanderheyden, M.2    Vandekerckhove, B.3
  • 19
    • 67649657795 scopus 로고    scopus 로고
    • Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial
    • Tendera M, Wojakowski W, Ruzyłło W, et al; REGENT Investigators. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009;30(11):1313-1321.
    • (2009) Eur Heart J , vol.30 , Issue.11 , pp. 1313-1321
    • Tendera, M.1    Wojakowski, W.2    Ruzyłło, W.3
  • 20
    • 85027946500 scopus 로고    scopus 로고
    • Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up
    • Vrtovec B, Poglajen G, Lezaic L, et al. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res. 2013;112(1):165-173.
    • (2013) Circ Res , vol.112 , Issue.1 , pp. 165-173
    • Vrtovec, B.1    Poglajen, G.2    Lezaic, L.3
  • 21
    • 84917679165 scopus 로고    scopus 로고
    • Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
    • Cogle CR, Wise E, Meacham AM, et al; Cardiovascular Cell Therapy Research Network (CCTRN). Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes. Circ Res. 2014;115(10):867-874.
    • (2014) Circ Res. , vol.115 , Issue.10 , pp. 867-874
    • Cogle, C.R.1    Wise, E.2    Meacham, A.M.3
  • 22
    • 34247119156 scopus 로고    scopus 로고
    • A role for cell sex in stem cell-mediated skeletal muscle regeneration: Female cells have higher muscle regeneration efficiency
    • Deasy BM, Lu A, Tebbets JC, et al. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol. 2007;177(1): 73-86.
    • (2007) J Cell Biol , vol.177 , Issue.1 , pp. 73-86
    • Deasy, B.M.1    Lu, A.2    Tebbets, J.C.3
  • 23
    • 80052376468 scopus 로고    scopus 로고
    • 10 Years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: From the methodological origin to clinical practice
    • Strauer B-E, Steinhoff G. 10 Years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011;58(11):1095-1104.
    • (2011) J Am Coll Cardiol , vol.58 , Issue.11 , pp. 1095-1104
    • Strauer, B.-E.1    Steinhoff, G.2
  • 24
    • 80053552289 scopus 로고    scopus 로고
    • Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease
    • Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109(8):923-940.
    • (2011) Circ Res , vol.109 , Issue.8 , pp. 923-940
    • Williams, A.R.1    Hare, J.M.2
  • 25
    • 84936856580 scopus 로고    scopus 로고
    • Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: Double-blind, randomized controlled trial
    • Gao LR, Chen Y, Zhang NK, et al. Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 2015;13:162.
    • (2015) BMC Med , vol.13 , pp. 162
    • Gao, L.R.1    Chen, Y.2    Zhang, N.K.3
  • 26
    • 84870887067 scopus 로고    scopus 로고
    • Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial
    • Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308(22):2369-2379.
    • (2012) JAMA , vol.308 , Issue.22 , pp. 2369-2379
    • Hare, J.M.1    Fishman, J.E.2    Gerstenblith, G.3
  • 27
    • 84938324717 scopus 로고    scopus 로고
    • Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: A randomized placebo-controlled trial (MSC-HF trial)
    • Mathiasen AB, Qayyum AA, Jørgensen E, et al. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J. 2015;36(27):1744-1753.
    • (2015) Eur Heart J , vol.36 , Issue.27 , pp. 1744-1753
    • Mathiasen, A.B.1    Qayyum, A.A.2    Jørgensen, E.3
  • 29
    • 10744228523 scopus 로고    scopus 로고
    • Adult cardiac stem cells are multipotent and support myocardial regeneration
    • Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6):763-776.
    • (2003) Cell , vol.114 , Issue.6 , pp. 763-776
    • Beltrami, A.P.1    Barlucchi, L.2    Torella, D.3
  • 30
    • 33847145871 scopus 로고    scopus 로고
    • Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens
    • Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115(7):896-908.
    • (2007) Circulation , vol.115 , Issue.7 , pp. 896-908
    • Smith, R.R.1    Barile, L.2    Cho, H.C.3
  • 31
    • 84858019974 scopus 로고    scopus 로고
    • Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial
    • Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379(9819):895-904.
    • (2012) Lancet , vol.379 , Issue.9819 , pp. 895-904
    • Makkar, R.R.1    Smith, R.R.2    Cheng, K.3
  • 32
    • 0037058848 scopus 로고    scopus 로고
    • Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)
    • Assmus B, Schächinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106 (24):3009-3017.
    • (2002) Circulation , vol.106 , Issue.24 , pp. 3009-3017
    • Assmus, B.1    Schächinger, V.2    Teupe, C.3
  • 33
    • 3042662157 scopus 로고    scopus 로고
    • Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction
    • Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94(1): 92-95.
    • (2004) Am J Cardiol , vol.94 , Issue.1 , pp. 92-95
    • Chen, S.L.1    Fang, W.W.2    Ye, F.3
  • 34
    • 3042710733 scopus 로고    scopus 로고
    • Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial
    • Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004; 364(9429):141-148.
    • (2004) Lancet , vol.364 , Issue.9429 , pp. 141-148
    • Wollert, K.C.1    Meyer, G.P.2    Lotz, J.3
  • 35
    • 33645743539 scopus 로고    scopus 로고
    • Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months’ follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration) trial
    • Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration) trial. Circulation. 2006;113 (10):1287-1294.
    • (2006) Circulation , vol.113 , Issue.10 , pp. 1287-1294
    • Meyer, G.P.1    Wollert, K.C.2    Lotz, J.3
  • 36
    • 30444432961 scopus 로고    scopus 로고
    • Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial
    • Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367(9505):113-121.
    • (2006) Lancet , vol.367 , Issue.9505 , pp. 113-121
    • Janssens, S.1    Dubois, C.2    Bogaert, J.3
  • 37
    • 33748910402 scopus 로고    scopus 로고
    • Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction
    • Schächinger V, Erbs S, Elsässer A, et al; REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355(12): 1210-1221.
    • (2006) N Engl J Med , vol.355 , Issue.12 , pp. 1210-1221
    • Schächinger, V.1    Erbs, S.2    Elsässer, A.3
  • 38
    • 33748899627 scopus 로고    scopus 로고
    • Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
    • Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355(12):1199-1209.
    • (2006) N Engl J Med , vol.355 , Issue.12 , pp. 1199-1209
    • Lunde, K.1    Solheim, S.2    Aakhus, S.3
  • 39
    • 56449121207 scopus 로고    scopus 로고
    • Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction
    • Huikuri HV, Kervinen K, Niemelä M, et al; FINCELL Investigators. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J. 2008;29(22): 2723-2732.
    • (2008) Eur Heart J , vol.29 , Issue.22 , pp. 2723-2732
    • Huikuri, H.V.1    Kervinen, K.2    Niemelä, M.3
  • 40
    • 70549103270 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction
    • Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54 (24):2277-2286.
    • (2009) J Am Coll Cardiol , vol.54 , Issue.24 , pp. 2277-2286
    • Hare, J.M.1    Traverse, J.H.2    Henry, T.D.3
  • 41
    • 58049192920 scopus 로고    scopus 로고
    • Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: The MYSTAR prospective, randomized study
    • Gyöngyösi M, Lang I, Dettke M, et al. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med. 2009;6(1):70-81.
    • (2009) Nat Clin Pract Cardiovasc Med , vol.6 , Issue.1 , pp. 70-81
    • Gyöngyösi, M.1    Lang, I.2    Dettke, M.3
  • 42
    • 68949162209 scopus 로고    scopus 로고
    • Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up
    • Cao F, Sun D, Li C, et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J. 2009;30 (16):1986-1994.
    • (2009) Eur Heart J , vol.30 , Issue.16 , pp. 1986-1994
    • Cao, F.1    Sun, D.2    Li, C.3
  • 43
    • 79960541758 scopus 로고    scopus 로고
    • Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: Results of the randomized multicenter BONAMI trial
    • Roncalli J, Mouquet F, Piot C, et al. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J. 2011;32(14):1748-1757.
    • (2011) Eur Heart J , vol.32 , Issue.14 , pp. 1748-1757
    • Roncalli, J.1    Mouquet, F.2    Piot, C.3
  • 44
    • 79960475582 scopus 로고    scopus 로고
    • Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: Results of the randomized controlled HEBE trial
    • Hirsch A, Nijveldt R, van der Vleuten PA, et al; HEBE Investigators. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J. 2011; 32(14):1736-1747.
    • (2011) Eur Heart J , vol.32 , Issue.14 , pp. 1736-1747
    • Hirsch, A.1    Nijveldt, R.2    Van Der Vleuten, P.A.3
  • 45
    • 81255208675 scopus 로고    scopus 로고
    • Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial
    • Traverse JH, Henry TD, Ellis SG, et al; Cardiovascular Cell Therapy ResearchNetwork. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011;306(19):2110-2119.
    • (2011) JAMA , vol.306 , Issue.19 , pp. 2110-2119
    • Traverse, J.H.1    Henry, T.D.2    Ellis, S.G.3
  • 46
    • 84870877380 scopus 로고    scopus 로고
    • Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: The TIME randomized trial
    • Traverse JH, Henry TD, Pepine CJ, et al; Cardiovascular Cell Therapy Research Network (CCTRN). Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012; 308(22):2380-2389.
    • (2012) JAMA , vol.308 , Issue.22 , pp. 2380-2389
    • Traverse, J.H.1    Henry, T.D.2    Pepine, C.J.3
  • 47
    • 84856193410 scopus 로고    scopus 로고
    • First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction
    • Houtgraaf JH, den Dekker WK, van Dalen BM, et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59(5):539-540.
    • (2012) J Am Coll Cardiol , vol.59 , Issue.5 , pp. 539-540
    • Houtgraaf, J.H.1    Den Dekker, W.K.2    Van Dalen, B.M.3
  • 48
    • 84877897377 scopus 로고    scopus 로고
    • Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute effects on global left ventricular function
    • Sürder D, Manka R, Lo Cicero V, et al. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute effects on global left ventricular function. Circulation. 2013; 127:1968-1979.
    • (2013) Circulation , vol.127 , pp. 1968-1979
    • Sürder, D.1    Manka, R.2    Lo Cicero, V.3
  • 49
    • 84930916898 scopus 로고    scopus 로고
    • Comparison of different bone marrow-derived stem cell approaches in reperfused STEMI: A multicenter, prospective, randomized, open-labeled TECAM trial
    • San Roman JA, Sánchez PL, Villa A, et al. Comparison of different bone marrow-derived stem cell approaches in reperfused STEMI: a multicenter, prospective, randomized, open-labeled TECAM trial. J Am Coll Cardiol. 2015;65(22):2372-2382.
    • (2015) J Am Coll Cardiol , vol.65 , Issue.22 , pp. 2372-2382
    • San Roman, J.A.1    Sánchez, P.L.2    Villa, A.3
  • 50
    • 34347402502 scopus 로고    scopus 로고
    • Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial
    • Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115(25):3165-3172.
    • (2007) Circulation , vol.115 , Issue.25 , pp. 3165-3172
    • Losordo, D.W.1    Schatz, R.A.2    White, C.J.3
  • 51
    • 65649129319 scopus 로고    scopus 로고
    • Intramyocardial bone marrow cell injection for chronic myocardial ischemia: A randomized controlled trial
    • van Ramshorst J, Bax JJ, Beeres SL, et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA. 2009;301(19):1997-2004.
    • (2009) JAMA , vol.301 , Issue.19 , pp. 1997-2004
    • Van Ramshorst, J.1    Bax, J.J.2    Beeres, S.L.3
  • 52
    • 80051748850 scopus 로고    scopus 로고
    • Intramyocardial, autologous CD34+ cell therapy for refractory angina
    • Losordo DW, Henry TD, Davidson C, et al; ACT34-CMI Investigators. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res. 2011;109(4):428-436.
    • (2011) Circ Res , vol.109 , Issue.4 , pp. 428-436
    • Losordo, D.W.1    Henry, T.D.2    Davidson, C.3
  • 53
    • 0037414086 scopus 로고    scopus 로고
    • Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction
    • Menasché P, Hagège AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003;41(7):1078-1083.
    • (2003) J Am Coll Cardiol , vol.41 , Issue.7 , pp. 1078-1083
    • Menasché, P.1    Hagège, A.A.2    Vilquin, J.T.3
  • 54
    • 0038701741 scopus 로고    scopus 로고
    • Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure
    • Perin EC, Dohmann HFR, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107(18):2294-2302.
    • (2003) Circulation , vol.107 , Issue.18 , pp. 2294-2302
    • Perin, E.C.1    Dohmann, H.F.R.2    Borojevic, R.3
  • 55
    • 33748899449 scopus 로고    scopus 로고
    • Transcoronary transplantation of progenitor cells after myocardial infarction
    • Assmus B, Honold J, Schächinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355 (12):1222-1232.
    • (2006) N Engl J Med , vol.355 , Issue.12 , pp. 1222-1232
    • Assmus, B.1    Honold, J.2    Schächinger, V.3
  • 56
    • 41149106402 scopus 로고    scopus 로고
    • The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation
    • Menasché P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008;117(9):1189-1200.
    • (2008) Circulation , vol.117 , Issue.9 , pp. 1189-1200
    • Menasché, P.1    Alfieri, O.2    Janssens, S.3
  • 57
    • 82255175382 scopus 로고    scopus 로고
    • Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial
    • Bolli R, Chugh AR, D’Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378(9806): 1847-1857.
    • (2011) Lancet , vol.378 , Issue.9806 , pp. 1847-1857
    • Bolli, R.1    Chugh, A.R.2    D’Amario, D.3
  • 58
    • 84860200127 scopus 로고    scopus 로고
    • Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: The FOCUS-CCTRN trial
    • Perin EC, Willerson JT, Pepine CJ, et al; Cardiovascular Cell Therapy Research Network (CCTRN). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012;307(16):1717-1726.
    • (2012) JAMA , vol.307 , Issue.16 , pp. 1717-1726
    • Perin, E.C.1    Willerson, J.T.2    Pepine, C.J.3
  • 59
    • 84870887067 scopus 로고    scopus 로고
    • Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial
    • Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308(22):2369-2379.
    • (2012) JAMA , vol.308 , Issue.22 , pp. 2369-2379
    • Hare, J.M.1    Fishman, J.E.2    Gerstenblith, G.3
  • 60
    • 84878722569 scopus 로고    scopus 로고
    • Cardiopoietic stem cell therapy in heart failure: The C-CURE
    • Bartunek J, Behfar A, Dolatabadi D, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE. J Am Coll Cardiol. 2013;61(23):2329-2338.
    • (2013) J Am Coll Cardiol , vol.61 , Issue.23 , pp. 2329-2338
    • Bartunek, J.1    Behfar, A.2    Dolatabadi, D.3
  • 61
    • 84876302976 scopus 로고    scopus 로고
    • Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: The CELLWAVE randomized clinical trial
    • Assmus B, Walter DH, Seeger FH, et al. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA. 2013; 309(15):1622-1631.
    • (2013) JAMA , vol.309 , Issue.15 , pp. 1622-1631
    • Assmus, B.1    Walter, D.H.2    Seeger, F.H.3
  • 62
    • 84903142251 scopus 로고    scopus 로고
    • Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
    • Perin EC, Sanz-Ruiz R, Sánchez PL, et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE Trial. Am Heart J. 2014;168(1):88-95.e2.
    • (2014) Am Heart J , vol.168 , Issue.1 , pp. 88-95.e2
    • Perin, E.C.1    Sanz-Ruiz, R.2    Sánchez, P.L.3
  • 63
    • 84891941987 scopus 로고    scopus 로고
    • Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: The TAC-HFT randomized trial
    • Heldman AW, DiFede DL, Fishman JE, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311(1):62-73.
    • (2014) JAMA , vol.311 , Issue.1 , pp. 62-73
    • Heldman, A.W.1    DiFede, D.L.2    Fishman, J.E.3
  • 66
    • 84916913763 scopus 로고    scopus 로고
    • Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences
    • Pavo N, Charwat S, Nyolczas N, et al. Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. J Mol Cell Cardiol. 2014;75:12-24.
    • (2014) J Mol Cell Cardiol , vol.75 , pp. 12-24
    • Pavo, N.1    Charwat, S.2    Nyolczas, N.3
  • 67
    • 48749100385 scopus 로고    scopus 로고
    • Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review
    • Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008; 29(15):1807-1818.
    • (2008) Eur Heart J , vol.29 , Issue.15 , pp. 1807-1818
    • Martin-Rendon, E.1    Brunskill, S.J.2    Hyde, C.J.3    Stanworth, S.J.4    Mathur, A.5    Watt, S.M.6
  • 68
    • 84969443678 scopus 로고    scopus 로고
    • Concise review: Review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease
    • Golpanian S, Schulman IH, Ebert RF, et al; Cardiovascular Cell Therapy Research Network. Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease. Stem Cells Transl Med. 2016;5(2): 186-191.
    • (2016) Stem Cells Transl Med , vol.5 , Issue.2 , pp. 186-191
    • Golpanian, S.1    Schulman, I.H.2    Ebert, R.F.3
  • 69
    • 84958780955 scopus 로고    scopus 로고
    • Cardiac stem cell treatment in myocardial infarction: A systematic review and meta-analysis of preclinical studies
    • Zwetsloot PP, Végh AM, Jansen Of Lorkeers SJ, et al. Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res. 2016;118(8):1223-1232.
    • (2016) Circ Res , vol.118 , Issue.8 , pp. 1223-1232
    • Zwetsloot, P.P.1    Végh, A.M.2    Jansen Of Lorkeers, S.J.3
  • 70
    • 1542315528 scopus 로고    scopus 로고
    • Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs
    • Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 2004;363(9411):783-784.
    • (2004) Lancet , vol.363 , Issue.9411 , pp. 783-784
    • Vulliet, P.R.1    Greeley, M.2    Halloran, S.M.3    MacDonald, K.A.4    Kittleson, M.D.5
  • 71
    • 84892394170 scopus 로고    scopus 로고
    • Intracoronary cardiosphere-derived cells after myocardial infarction: Evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (Cardiosphere-Derived Autologous Stem Cells to Reverse Ventricular Dysfunction)
    • Malliaras K, Makkar RR, Smith RR, et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (Cardiosphere-Derived Autologous Stem Cells to Reverse Ventricular Dysfunction). J Am Coll Cardiol. 2014;63(2):110-122.
    • (2014) J Am Coll Cardiol , vol.63 , Issue.2 , pp. 110-122
    • Malliaras, K.1    Makkar, R.R.2    Smith, R.R.3
  • 72
    • 77958137275 scopus 로고    scopus 로고
    • Intracoronary autologous CD34+ stem cell therapy for intractable angina
    • Wang S, Cui J, Peng W, Lu M. Intracoronary autologous CD34+ stem cell therapy for intractable angina. Cardiology. 2010;117(2):140-147.
    • (2010) Cardiology , vol.117 , Issue.2 , pp. 140-147
    • Wang, S.1    Cui, J.2    Peng, W.3    Lu, M.4
  • 73
    • 84901952623 scopus 로고    scopus 로고
    • Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices
    • Ascheim DD, Gelijns AC, Goldstein D, et al. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation. 2014;129(22):2287-2296.
    • (2014) Circulation , vol.129 , Issue.22 , pp. 2287-2296
    • Ascheim, D.D.1    Gelijns, A.C.2    Goldstein, D.3
  • 74
    • 84958123357 scopus 로고    scopus 로고
    • Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design
    • Bartunek J, Davison B, Sherman W, et al. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design. Eur J Heart Fail. 2016;18(2):160-168.
    • (2016) Eur J Heart Fail , vol.18 , Issue.2 , pp. 160-168
    • Bartunek, J.1    Davison, B.2    Sherman, W.3
  • 75
    • 84899654158 scopus 로고    scopus 로고
    • Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): Weighted regression and meta-analysis
    • Nowbar AN, Mielewczik M, Karavassilis M, et al; DAMASCENE writing group. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014; 348:g2688.
    • (2014) BMJ , vol.348 , pp. g2688
    • Nowbar, A.N.1    Mielewczik, M.2    Karavassilis, M.3
  • 76
    • 84892762560 scopus 로고    scopus 로고
    • Moving beyond surrogate endpoints in cell therapy trials for heart disease
    • Malliaras K, Marbán E. Moving beyond surrogate endpoints in cell therapy trials for heart disease. Stem Cells Transl Med. 2014;3(1):2-6.
    • (2014) Stem Cells Transl Med , vol.3 , Issue.1 , pp. 2-6
    • Malliaras, K.1    Marbán, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.